Significance of cerebrospinal fluid sIL-2R level as a marker of CNS involvement in acute lymphoblastic leukemia

Annals of Clinical and Laboratory Science

Volumn 35, Issue 4, 2005, Pages 407-412

  Lee, Wonbae ^a   Kim, Sung Joon ^a   Lee, Soonwook ^a   Kim, Jayoung ^a   Kim, Myungshin ^a   Lim, Jihyang ^a   Kim, Yonggoo ^a   Cho, Bin ^a   Lee, Eun Jung ^a   Han, Kyungja ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Acute lymphoblastic leukemia; Cerebrospinal fluid; CNS relapse; sIL 2R

Indexed keywords

ASPARTATE AMINOTRANSFERASE; GLUCOSE; INTERLEUKIN 2 RECEPTOR; LACTATE DEHYDROGENASE; PROTEIN; URIC ACID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; CYTOLOGY; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SENSITIVITY AND SPECIFICITY;

CENTRAL NERVOUS SYSTEM NEOPLASMS; CEREBROSPINAL FLUID; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; NEOPLASM RECURRENCE, LOCAL; RECEPTORS, INTERLEUKIN-2; RECURRENCE; REFERENCE VALUES; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 27644483227     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Kim JP, Cho D, Kee SJ, Shin JH, Suh SP, Ryang DW. Morphologic, immunophenotypic, and cytogenetic findings in 339 patients with acute leukemia. Korean J Lab Med 2002;22:213-219.
2. Chessells JM. Relapsed lymphoblastic leukaemia in children: a continuing challenge. Br J Haematol 1998;102:423-438.
3. Chessells JM. The management of high-risk lymphoblastic leukaemia in children. Br J Haematol 2000;108:204-216.
4. Price RA, Johnson WW. The central nervous system in childhood leukemia, I. The arachnoid. Cancer 1973;31:520-533.
5. LeClerc JM, Billett AL, Gelber RD, Dalton V, Tarbell N, Lipton JM, Barr R, Clavell LA, Asselin B, Hurwitz C, Schorin M, Lipshultz SE, Declerck L, Silverman LB, Cohen HJ, Sallan SE. Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01. J Clin Oncol 2002;20:237-246.
6. McIntosh S, Ritchey AK. Diagnostic problems in cerebrospinal fluid of children with lymphoid malignancies. Am J Pediatr Hematol Oncol 1986;8:28-31.
7. Oner AF, Yetgin S, Uckan D. Cerebrospinal fluid pleocytosis in acute lymphoblastic leukemia without central nervous system relapse: a report of three cases. Turk J Pediatr 1999;41:249-251.
8. Scrideli CA, Queiroz RP, Takayanagui OM, Bernardes JE, Tone LG. Polymerase chain reaction on cerebrospinal fluid cells in suspected leptomeningeal involvement in childhood acute lymphoblastic leukemia: comparison to cytomorphological analysis. Diagn Mol Pathol 2003;12:124-127.
9. Galoin S, Daste G, Apoil PA, Chollet F, Roda D, Blancher A, Delsol G, Chittal S, al Saati T. Polymerase chain reaction on cerebrospinal fluid cells in the detection of leptomeningeal involvement by B-cell lymphoma and leukaemia: a novel strategy and its implications. Br J Haematol 1997;99:122-130.
10. Kamihira S, Atogami S, Sohda H, Momita S, Yamada Y, Tomonaga M. Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia. Cancer 1994;73:2753-2758.
11. Motokura T, Kobayashi Y, Fujita A, Nakamura Y, Taniguchi T, Uchimaru K, Asano S. Clinical significance of serial measurement of the serum levels of soluble interleukin-2 receptor and soluble CD8 in malignant lymphoma. Leuk Lymphoma 1995;16:355-362.
12. Kalmanti M, Karamolengou K, Dimitriou H, Tosca A, Vlachonikolis I, Peraki M, Georgoulias V, Kalmantis T. Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma. Int J Hematol 1993;57:147-152.
13. Niitsu N, Iijima K, Chizuka A. A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma. Eur J Haematol 2001;66:24-30.
14. Ohno H, Ishikawa T, Kitajima H, Nomura S, Suzuki T, Konishi H, Ohno Y, Onishi R, Konaka Y, Arima N, Doi S, Nasu K, Takahashi T, Tsudo M, Fukuhara S, Uchiyama T. Significance of soluble interleukin-2 receptor alpha chain in the management of patients with malignant lymphoma: a multi-center study. Rinsho Ketsueki. 2002;43:170-175.
15. Moon Y, Kim Y, Kim M, Lim J, Pai SH, Lee EJ, Kang CS, Kim WI, Shim SI, Chung NG, Park YH, Min WS, Han K. Plasma soluble interleukin-2 receptor (sIL-2R) levels in patients with acute leukemia. Ann Clin Lab Sci 2004;34:410-415.
16. Gilchrist GS, Tubergen DG, Sather HN, Coccia PF, O'Brien RT, Waskerwitz MJ, Hammond GD. Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia. J Clin Oncol 1994;12:2594-2600.
17. Burger B, Zimmermann M, Mann G, Kuhl J, Loning L, Riehm H, Reiter A, Schrappe M. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol 2003;21:184-188.
18. Silverman LB, Declerck L, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Lipton JM, Cohen HJ, Sallan SE. Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995). Leukemia 2000;14:2247-2256.
19. Hann IM, Richards SM, Eden OB, Hill FG. Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party. Leukemia 1998;12:1249-1255.
20. Reaman G, Zeltzer P, Bleyer WA, Amendola B, Level C, Sather H, Hammond D. Acute lymphoblastic leukemia in infants less than one year of age: a cumulative experience of the Children's Cancer Study Group. J Clin Oncol 1985;3:1513-1521.
21. Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui CH, Pullen J, Reamon G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996;14:18-24.
22. Rivera GK, Pinkel D, Simone JV, Hancock ML, Crist WM. Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital. NEJM 1993;329:1289-1295.
23. Kun LE, Camitta BM, Mulhern RK, Lauer SJ, Kline RW, Casper JT, Kamen BA, Kaplan BM, Barber SW. Treatment of meningeal relapse in childhood acute lymphoblastic leukemia. I. Results of craniospinal irradiation. J Clin Oncol 1984;2:359-364.
24. Behrendt H, van Leeuwen EF, Schuwirth C, Verkes RJ, Hermans J, van der Does-van den Berg A, van Wering ER. Significance of an isolated central nervous system relapse, occurring as first relapse in children with acute lymphoblastic leukemia. Cancer 1989;63:2066-2072.
25. Winick NJ, Smith SD, Shuster J, Lauer S, Wharam MD, Land V, Buchanan G, Rivera G. Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study. J Clin Oncol 1993;11:271-278.
26. Ritchey AK, Pollock BH, Lauer SJ, Andejeski Y, Barredo J, Buchanan GR. Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study. J Clin Oncol 1999;17:3745-3752.
27. Wheeler K, Richards S, Bailey C, Chessells J. Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia. Br J Haematol 1998;101:94-103.
28. Gaynon PS, Qu RP, Chappell RJ, Willoughby ML, Tubergen DG, Steinherz PG, Trigg ME. Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse-the Children's Cancer Group Experience. Cancer 1998;82:1387-1395.
29. Waber DP, Tarbell NJ. Toxicity of CNS prophylaxis for childhood leukemia. Oncology 1997;11:259-264.
30. Ochs J, Mulhern RK. Late effects of antileukemic treatment. Pediatr Clin North Am 1988;35:815-833.
31. George SL, Ochs JJ, Mauer AM, Simone JV. The importance of an isolated central nervous system relapse in children with acute lymphoblastic leukemia. J Clin Oncol 1985;3:776-781.
32. Rivera GK, Pinkel D, Simone JV, Hancock ML, Crist WM. Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital. NEJM 1993;329:1289-1295.
33. Chessells JM. Pitfalls in the diagnosis of childhood leukaemia. Br J Haematol 2001;114:506-511.
34. Hooijkaas H, Hahlen K, Adriaansen HJ, Dekker I, van Zanen GE, van Dongen JJ. Terminal deoxynucleotidyl transferase (TdT)-positive cells in cerebrospinal fluid and development of overt CNS leukemia: 5-year follow-up study in 113 children with a TdT-positive leukemia or non-Hodgkin's lymphoma. Blood 1989;74:416-422.
35. Lossos IS, Breuer R, Intrator O, Lossos A. Cerebrospinal fluid lactate dehydrogenase isoenzyme analysis for the diagnosis of central nervous system involvement in hematooncologic patients. Cancer 2000;88:1599-1604.
36. Gilchrist GS, Tubergen DG, Sather HN, Coccia PF, O'Brien RT, Waskerwitz MJ, Hammond GD. Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Children's Cancer Group report. J Clin Oncol 1994;12:2594-2600.
37. Burger B, Zimmermann M, Mann G, Kuhl J, Loning L, Riehm H, Reiter A, Schrappe M. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol 2003;21:184-188.
38. Tubergen DG, Cullen JW, Boyett JM, Gilchrist GS, O'Brien RT, Coccia PF, Waskerwitz MJ. Blasts in CSF with a normal cell count do not justify alteration of therapy for acute lymphoblastic leukemia in remission: a Children's Cancer Group study. J Clin Oncol 1994;12:273-278.
39. Mahmoud HH, Rivera GK, Hancock ML, Krance RA, Kun LE, Behm FG, Ribeiro RC, Sandlund JT, Crist WM, Pui CH. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. NEJM 1993;329:314-319.
40. Lahoda F, Athen D. Typing of uric acid level in cerebrospinal fluid in neurological and psychiatric diseases. Adv Exp Med Biol 1977;76B:256-258.
41. Flanagan NG, Ridway JC, Platt CC, Rowlands AJ, Whitson A. Lactic dehydrogenase estimation in haematological malignancies. Clin Lab Haematol 1989;11:17-26.